Is there more upside in store for pharma stocks?
Over the past year, the Nifty Pharma Index has gained 23% while the Nifty has declined by 11%
June 30, 2020
Veteran fund manager and CIO of HDFC AMC sells one-third of his stake in the company worth Rs.747 million
Shailaja Mohapatra - July 03, 2020
Will Moody's downgrade result in more FII outflows?
FIIs have YTD sold Rs.612 billion, but the latest negative rating might hurt investor sentiment again
June 05, 2020
What does Rakesh Jhunjhunwala see in Jubilant Life Sciences?
Within a year, the investing legend has doubled down on his latest pharma bet
Himanshu Kakkar - May 23, 2020
“This is 3-4x bigger than the 2008 crisis”
Despite the sharp correction in the Indian market, Sridhar Sivaram, investment director at Enam Holdings, has decided to stay away till volatility peaks out
April 25, 2020
In cash we trust
Paritosh Kashyap sells Kotak Mahindra Bank shares worth Rs.151 million
April 25, 2020
Quit India 2.0
With overreaching bureaucracy and overzealous taxation, doing business in the country has become cumbersome. Many entrepreneurs are lining up Plan B
V Keshavdev - March 04, 2020
Fintech companies are offering investors cheaper advice for increasing their wealth
Prathamesh Mulye - March 02, 2020
The road not ahead
The macro headwind may be getting worse for the infra sector, but a handful of companies with robust order book could just weather the dust storm
Prathamesh Mulye - January 08, 2020
"Investing during a slowdown is a no-brainer"
Crises give you great opportunities to be adventurous and transform your business, says IBM India MD Karan Bajwa
December 10, 2019